I’m normally quite harsh and have been harsh with Sensera’s performance but credit where it is due, this is actually a good quarterly. Don’t really care about what some loose holders think.
Revenue record.
Expenses nil increase
Acquisition commitments complete
Zoetis 3000 sales force in full swing this quarter
Abiomed ramping into production
I don’t see any issues. In fact, I only see positives.
Ann: Appendix 4C - quarterly, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
